Summary
- Revenue
- SEEL current annual revenue is $2.20M, up +100.00% year-over-year
- Next Earnings
- As of today, the next earnings release for SEEL has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Seelos Therapeutics, Inc. |
| Ticker | NASDAQ: SEEL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | seelostherapeutics.com |
| Employees | 8 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| - | ||
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| N/A | - | |
| $2M | ||
| Revenue, 1Y Change | +100.00% | |
| -$989.53 | ||
| EPS, 1Y Change | +62.73% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:16 | |
| Next Split | N/A | N/A |
| Last Ticker Change | APRI | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$989.53 | ||
| EPS Estimate | N/A | -$4.09 |
| EPS Est. Change | N/A | +99.59% |
| $2.20M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| - | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.41 | -$989.53 | -241,247.76% | |
| -$4.09 | N/A | +99.59% | |
| - | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.20M | $2.20M | 0.00% | |
| - | N/A | - | |
| $28.40M | N/A | +1,189.15% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| +100.00% | ||
| +100.00% | ||
| +62.73% | ||
| +39.61% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| - | ||
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $2.20M | ||
| -$989.53 | ||
| $2.15M | ||
| 97.41% | ||
| -$40.50M | ||
| -1,838.36% | ||
| -$37.88M | ||
| -1,719.56% | ||
| -$37.75M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.42 | ||
| 0.14 | ||
| 0.14 | ||
| - | ||
| 5 | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$33.51M | ||
| $3.00M | ||
| $5.42M | ||
| $5.40M | ||
| $38.93M | ||
| $38.93M | ||
| $14.23M | ||
| $14.23M | ||
| $16.40M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $40.50M | ||
| $40.50M | ||
| $57.00K | ||
| $12.59M | ||
| $57.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$23.91M | ||
| $0.00 | ||
| $11.38M | ||
| $0.00 | ||
| -$23.91M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Guggenheim | → | |
| Guggenheim | → | |
| Cantor Fitzgerald | → | |
| Benchmark | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | → | |
| Benchmark | → | |
| BTIG | → | |
| Cantor Fitzgerald | → |
Analyst sentiment
Institutional ownership
Screeners with SEEL
FAQ
- What is the ticker symbol for Seelos Therapeutics, Inc.?
- The ticker symbol for Seelos Therapeutics, Inc. is NASDAQ:SEEL
- Does Seelos Therapeutics, Inc. pay dividends?
- No, Seelos Therapeutics, Inc. does not pay dividends
- What sector is Seelos Therapeutics, Inc. in?
- Seelos Therapeutics, Inc. is in the Healthcare sector
- What industry is Seelos Therapeutics, Inc. in?
- Seelos Therapeutics, Inc. is in the Biotechnology industry
- What country is Seelos Therapeutics, Inc. based in?
- Seelos Therapeutics, Inc. is headquartered in United States
- When did Seelos Therapeutics, Inc. go public?
- Seelos Therapeutics, Inc. initial public offering (IPO) was on April 19, 1999
- Is Seelos Therapeutics, Inc. in the S&P 500?
- No, Seelos Therapeutics, Inc. is not included in the S&P 500 index
- Is Seelos Therapeutics, Inc. in the NASDAQ 100?
- No, Seelos Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Seelos Therapeutics, Inc. in the Dow Jones?
- No, Seelos Therapeutics, Inc. is not included in the Dow Jones index
- When was Seelos Therapeutics, Inc. last earnings report?
- Seelos Therapeutics, Inc.'s most recent earnings report was on November 21, 2024
- When does Seelos Therapeutics, Inc. report earnings?
- The date for Seelos Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- SEEL Official Website seelostherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1017491/000141057824001435/0001410578-24-001435-index.htm
- SEEL Profile on Yahoo Finance finance.yahoo.com/quote/SEEL
- SEEL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/seel